-+ 0.00%
-+ 0.00%
-+ 0.00%
Oncopeptides Names Four-Member Nomination Committee for 2027 AGM
Share
Listen to the news
Oncopeptides Names Four-Member Nomination Committee for 2027 AGM
  • Oncopeptides established its nomination committee for the 2027 annual general meeting on November 20, 2026.
  • Staffan Lindstrand was appointed by HealthCap VI L.P. and HealthCap VIII L.P.
  • Ulf Nolén joins as a representative of his own shareholding.
  • Philip Lennhammer was appointed by Madeleine Lennhammer.
  • The committee represents approximately 16% of voting rights, based on shareholder information at the end of September 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncopeptides AB published the original content used to generate this news brief on November 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending